Cargando…
Management of type 2 diabetes in the new era
PURPOSE: Management of type 2 diabetes is advancing beyond glycemic control and is increasingly based on cardiovascular risk stratification. This review summarizes recent advances in the field and identifies existing knowledge gaps and areas of ongoing research. METHODS: A bibliographic search was c...
Autores principales: | Liakos, Aris, Karagiannis, Thomas, Avgerinos, Ioannis, Malandris, Konstantinos, Tsapas, Apostolos, Bekiari, Eleni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651701/ https://www.ncbi.nlm.nih.gov/pubmed/37700155 http://dx.doi.org/10.1007/s42000-023-00488-w |
Ejemplares similares
-
Cardiovascular Risk Reduction in Type 2 Diabetes: Therapeutic Potential of Dapagliflozin
por: Avgerinos, Ioannis, et al.
Publicado: (2019) -
Comparative efficacy of glucose-lowering drugs on liver steatosis as assessed by means of magnetic resonance imaging in patients with type 2 diabetes mellitus: systematic review and network meta-analysis
por: Malandris, Konstantinos, et al.
Publicado: (2023) -
Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis
por: Karagiannis, Thomas, et al.
Publicado: (2022) -
Canagliflozin in the treatment of type 2 diabetes: an evidence-based review of its place in therapy
por: Karagiannis, Thomas, et al.
Publicado: (2017) -
Socioeconomic aspects of incretin-based therapy
por: Karagiannis, Thomas, et al.
Publicado: (2023)